Aquestive Therapeutics Inc (AQST) stock news · rev $44.5M
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
This AQST news page leads with what Aquestive Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for AQST yet. We will not pad this page with generic market recap.
Latest reported AQST revenue for 2025-12-31 was $44.5M. Net income was -$83.8M. Revenue was down 22.6% from 2024-12-31 to 2025-12-31. AQST currently screens at market cap $493.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AQST stock page; for the tape open the quote page.
AQST stock news FAQ
What are AQST's latest revenue and net income?
Latest cached Aquestive Therapeutics Inc (AQST) revenue for Dec 31, 2025 was $44.5M. Net income was -$83.8M. Statements: https://lician.com/financials/aqst
How did AQST revenue change from the prior cached period?
Cached Aquestive Therapeutics Inc (AQST) revenue was down 22.6% from $57.6M (Dec 31, 2024) to $44.5M (Dec 31, 2025). Statements: https://lician.com/financials/aqst
What is AQST's market cap?
Aquestive Therapeutics Inc (AQST) market cap is $493.0M on the latest cached fundamentals snapshot.
What kind of company is AQST?
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Where is AQST stock news listed?
Cached stock news for Aquestive Therapeutics Inc (AQST) is listed at https://lician.com/news/aqst. Filings: https://lician.com/sec/aqst
Not investment advice.